Excalibur Management Corp Gsk PLC Transaction History

Excalibur Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$42.05 - $47.77 $582,728 - $661,996	-13,858 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$40.23 - $47.74 $683 - $811	-17 Reduced 0.12%	13,858 $604,000
Q4 2021 Feb 10, 2022	SELL	$38.88 - $45.31 $11,352 - $13,230	-292 Reduced 2.06%	13,875 $612,000
Q3 2021 Oct 28, 2021	BUY	$38.79 - $43.16 $10,861 - $12,084	280 Added 2.02%	14,167 $541,000
Q2 2021 Jul 26, 2021	BUY	$36.52 - $41.46 $11,832 - $13,433	324 Added 2.39%	13,887 $553,000
Q1 2021 May 03, 2021	BUY	$34.27 - $40.01 $155,585 - $181,645	4,540 Added 50.32%	13,563 $484,000
Q4 2020 Jan 26, 2021	BUY	$34.07 - $39.94 $21,736 - $25,481	638 Added 7.61%	9,023 $332,000
Q3 2020 Nov 02, 2020	BUY	$38.11 - $42.99 $24,009 - $27,083	630 Added 8.12%	8,385 $316,000
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $12,118 - $13,945	320 Added 4.3%	7,755 $316,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $4,545 - $6,836	-140 Reduced 1.85%	7,435 $282,000
Q4 2019 Feb 04, 2020	BUY	$42.0 - $48.25 $318,150 - $365,493	7,575 New	7,575 $356,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

Stay updated on Excalibur Management Corp with notifications on news.